Diagnostics and research stocks with the fastest earnings growth

Ranked

17

of 74 diagnostics and research stocks we cover

Median

+12.5%

Highest

+115.6%

CDNA

Range

−67.1% to +115.6%

#	Company	EPS growth	PE	Revenue growth (TTM)	Market cap
1	CDNACareDx	+115.6%	33.4×	+34.4%	$3.6B
2	LHLabcorp	+33.3%	27.2×	+6.4%	$26.7B
3	MEDPMedpace	+26.8%	39.2×	+24.7%	$18.7B
4	DHRDanaher	+19.8%	40.9×	+4.6%	$162B
5	AAgilent Technologies	+19.2%	34.0×	+8.6%	$48.8B
6	IDXXIDEXX Laboratories	+18.4%	39.4×	+12.8%	$44.1B
7	DGXQuest Diagnostics	+18.3%	25.7×	+9.1%	$26.7B
8	IQVIQVIA	+16.6%	34.7×	+8.2%	$46B
9	MTDMettler-Toledo International	+12.5%	37.6×	+6.9%	$33.5B
10	LNTHLantheus	+9.8%	24.2×	+2.3%	$6.5B
11	TMOThermo Fisher Scientific	+9.5%	35.5×	+8.3%	$249.1B
12	RVTYRevvity	−11.0%	75.6×	+4.1%	$17.7B
13	BIOBio-Rad Laboratories	−29.7%	44.8×	+1.4%	$9.9B
14	ILMNIllumina	−32.0%	50.1×	+4.9%	$40.7B
15	ICCCImmucell	−57.9%	128×	+8.5%	$93.1M
16	WATWaters	−63.8%	113×	+52.5%	$44.6B
17	NRCNRC Health	−67.1%	87.7×	−0.2%	$485.1M

Not ranked: 48 with not a meaningful number, 4 with no profit to compare, 1 with a quarter missing, 1 with growth above 300% (a base too small to compare). 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.